01:44:49 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



Sirona Biochem Corp
Symbol SBM
Shares Issued 229,514,820
Close 2021-03-31 C$ 0.395
Market Cap C$ 90,658,354
Recent Sedar Documents

Sirona Biochem's TFC-1067 results show spot decrease

2021-03-31 07:13 ET - News Release

Dr. Howard Verrico reports

SIRONA BIOCHEM REPORTS EXCELLENT RESULTS IN NEW CLINICAL STUDY ON TFC-1067

The second clinical trial of Sirona Biochem Corp.'s active ingredient, TFC-1067, has been completed with excellent results.

The trial, which concluded on Jan. 22, 2021, was managed by Dermscan (a division of Eurofins), a global leader in cosmetic clinical trials. The study's end point was to determine the compound's ability to selectively reduce areas of hyperpigmentation and dark spots of the skin while not creating a halo around the spot, which is a known side effect of other treatments. Multiple parameters were measured, including the added effects of the higher concentration of TFC-1067 and a boosted formulation.

Results of the trial included:

  • A significant decrease in spot intensity;
  • A significant decrease in spot size;
  • A significant decrease in dark spots versus surrounding skin tone.

Optimal results were obtained with the higher concentration and improved formulation:

  • One hundred per cent of participants agreed their complexion was illuminated.
  • One hundred per cent of participants agreed their complexion was brighter.
  • One hundred per cent of participants agreed their skin was more even in tone.
  • One hundred per cent of participants agreed the product blurred imperfections.
  • One hundred per cent of participants agreed the product prevented new dark spots from occurring.
  • One hundred per cent of participants agreed the spot size and mark were reduced.
  • One hundred per cent of participants agreed the intensity of dark spots was reduced.
  • One hundred per cent of participants would purchase the product.

Due to contractual obligations, further disclosures will not be made at this time.

The company also reports an increase in international interest in the project since the commercial launch of TFC-1067.

About Sirona Biochem Corp.

Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential.

Sirona's compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and continuing royalty payments. Sirona's laboratory, TFChem, is located in France and is the recipient of multiple French national scientific awards and European Union and French government grants.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.